vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Vera Bradley, Inc. (VRA). Click either name above to swap in a different company.

Vera Bradley, Inc. is the larger business by last-quarter revenue ($62.3M vs $40.7M, roughly 1.5× PETMED EXPRESS INC). Vera Bradley, Inc. runs the higher net margin — -19.9% vs -26.0%, a 6.1% gap on every dollar of revenue. On growth, Vera Bradley, Inc. posted the faster year-over-year revenue change (-22.7% vs -23.3%). Vera Bradley, Inc. produced more free cash flow last quarter ($-4.5M vs $-9.2M). Over the past eight quarters, Vera Bradley, Inc.'s revenue compounded faster (16.1% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Vera Bradley Sales, LLC is an American luggage and handbag design company, founded by Barbara Bradley Baekgaard and Patricia R. Miller in 1982. As of 2019, its home office is in Fort Wayne, Indiana. The company was named after Baekgaard's mother. Its original luxury cotton bag product lines have expanded to include fashion and home accessories, office supplies, and patterned gifts. Many items have distinctive florals, paisleys, or geometric prints with complementary linings, as well as elonga...

PETS vs VRA — Head-to-Head

Bigger by revenue
VRA
VRA
1.5× larger
VRA
$62.3M
$40.7M
PETS
Growing faster (revenue YoY)
VRA
VRA
+0.5% gap
VRA
-22.7%
-23.3%
PETS
Higher net margin
VRA
VRA
6.1% more per $
VRA
-19.9%
-26.0%
PETS
More free cash flow
VRA
VRA
$4.8M more FCF
VRA
$-4.5M
$-9.2M
PETS
Faster 2-yr revenue CAGR
VRA
VRA
Annualised
VRA
16.1%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
PETS
PETS
VRA
VRA
Revenue
$40.7M
$62.3M
Net Profit
$-10.6M
$-12.4M
Gross Margin
23.3%
42.1%
Operating Margin
-25.7%
-19.6%
Net Margin
-26.0%
-19.9%
Revenue YoY
-23.3%
-22.7%
Net Profit YoY
-1392.6%
3.4%
EPS (diluted)
$-0.50
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
VRA
VRA
Q4 25
$40.7M
$62.3M
Q3 25
$44.4M
$70.9M
Q2 25
$51.2M
$51.7M
Q1 25
$50.8M
$100.0M
Q4 24
$52.0M
$70.5M
Q3 24
$58.0M
$94.0M
Q2 24
$66.2M
$67.9M
Q1 24
$65.1M
$46.2M
Net Profit
PETS
PETS
VRA
VRA
Q4 25
$-10.6M
$-12.4M
Q3 25
$-8.5M
$-4.7M
Q2 25
$-34.2M
$-33.5M
Q1 25
$-11.6M
$-47.0M
Q4 24
$-707.0K
$-12.8M
Q3 24
$2.3M
$5.7M
Q2 24
$3.8M
$-8.1M
Q1 24
$-5.0M
$-1.9M
Gross Margin
PETS
PETS
VRA
VRA
Q4 25
23.3%
42.1%
Q3 25
28.0%
50.1%
Q2 25
28.1%
44.1%
Q1 25
29.9%
45.0%
Q4 24
31.0%
54.5%
Q3 24
32.3%
49.7%
Q2 24
28.8%
50.1%
Q1 24
29.3%
37.2%
Operating Margin
PETS
PETS
VRA
VRA
Q4 25
-25.7%
-19.6%
Q3 25
-18.9%
-6.5%
Q2 25
-66.7%
-34.6%
Q1 25
-11.9%
-23.3%
Q4 24
-0.9%
-11.6%
Q3 24
1.0%
2.5%
Q2 24
6.6%
-15.6%
Q1 24
-5.9%
-3.6%
Net Margin
PETS
PETS
VRA
VRA
Q4 25
-26.0%
-19.9%
Q3 25
-19.2%
-6.6%
Q2 25
-66.7%
-64.8%
Q1 25
-22.9%
-47.0%
Q4 24
-1.4%
-18.2%
Q3 24
4.0%
6.1%
Q2 24
5.7%
-12.0%
Q1 24
-7.7%
-4.0%
EPS (diluted)
PETS
PETS
VRA
VRA
Q4 25
$-0.50
$-0.44
Q3 25
$-0.41
$-0.17
Q2 25
$-1.65
$-1.20
Q1 25
$-0.56
$-1.62
Q4 24
$-0.03
$-0.46
Q3 24
$0.11
$0.19
Q2 24
$0.18
$-0.26
Q1 24
$-0.24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
VRA
VRA
Cash + ST InvestmentsLiquidity on hand
$26.9M
$10.7M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$32.8M
$128.1M
Total Assets
$88.0M
$243.7M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
VRA
VRA
Q4 25
$26.9M
$10.7M
Q3 25
$36.1M
$15.2M
Q2 25
$41.1M
$11.3M
Q1 25
$54.7M
$30.4M
Q4 24
$50.1M
$13.7M
Q3 24
$52.0M
$44.1M
Q2 24
$46.0M
$55.2M
Q1 24
$55.3M
$77.3M
Total Debt
PETS
PETS
VRA
VRA
Q4 25
$10.0M
Q3 25
$10.0M
Q2 25
Q1 25
$0
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PETS
PETS
VRA
VRA
Q4 25
$32.8M
$128.1M
Q3 25
$43.1M
$140.5M
Q2 25
$51.5M
$146.0M
Q1 25
$85.1M
$179.0M
Q4 24
$96.2M
$225.2M
Q3 24
$96.4M
$242.5M
Q2 24
$93.5M
$245.9M
Q1 24
$96.7M
$259.9M
Total Assets
PETS
PETS
VRA
VRA
Q4 25
$88.0M
$243.7M
Q3 25
$100.3M
$266.2M
Q2 25
$109.8M
$267.9M
Q1 25
$148.7M
$306.7M
Q4 24
$144.8M
$359.0M
Q3 24
$146.0M
$379.2M
Q2 24
$152.7M
$368.7M
Q1 24
$169.9M
$380.8M
Debt / Equity
PETS
PETS
VRA
VRA
Q4 25
0.08×
Q3 25
0.07×
Q2 25
Q1 25
0.00×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
VRA
VRA
Operating Cash FlowLast quarter
$-9.2M
$-4.0M
Free Cash FlowOCF − Capex
$-9.2M
$-4.5M
FCF MarginFCF / Revenue
-22.7%
-7.2%
Capex IntensityCapex / Revenue
0.1%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
VRA
VRA
Q4 25
$-9.2M
$-4.0M
Q3 25
$-2.2M
$-5.4M
Q2 25
$-12.3M
$-17.9M
Q1 25
$7.0M
$21.7M
Q4 24
$-1.2M
$-22.6M
Q3 24
$7.4M
$1.4M
Q2 24
$-8.5M
$-14.5M
Q1 24
$7.1M
$26.9M
Free Cash Flow
PETS
PETS
VRA
VRA
Q4 25
$-9.2M
$-4.5M
Q3 25
$-4.8M
$-6.1M
Q2 25
$-13.6M
$-19.8M
Q1 25
$4.6M
$17.3M
Q4 24
$-1.9M
$-25.0M
Q3 24
$6.1M
$-1.4M
Q2 24
$-9.2M
$-15.4M
Q1 24
$5.9M
$25.7M
FCF Margin
PETS
PETS
VRA
VRA
Q4 25
-22.7%
-7.2%
Q3 25
-10.8%
-8.7%
Q2 25
-26.5%
-38.3%
Q1 25
9.1%
17.3%
Q4 24
-3.7%
-35.5%
Q3 24
10.6%
-1.5%
Q2 24
-13.9%
-22.7%
Q1 24
9.0%
55.7%
Capex Intensity
PETS
PETS
VRA
VRA
Q4 25
0.1%
0.7%
Q3 25
5.9%
1.0%
Q2 25
2.5%
3.6%
Q1 25
4.7%
4.3%
Q4 24
1.5%
3.4%
Q3 24
2.2%
3.0%
Q2 24
1.0%
1.3%
Q1 24
1.9%
2.6%
Cash Conversion
PETS
PETS
VRA
VRA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
0.25×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

VRA
VRA

Bags$23.9M38%
Indirect$12.6M20%
Transferred At Point In Time$12.2M20%
Accessories$7.2M12%
Home$3.5M6%
Apparel Footwear$1.8M3%
Other Products$1.5M2%

Related Comparisons